Aardvark Therapeutics, Inc. (AARD)

Aardvark Therapeutics Statistics

Total Valuation

AARD has a market cap or net worth of $82.47 million. The enterprise value is -$4.91 million.

Market Cap	82.47M
Enterprise Value	-4.91M

Important Dates

The last earnings date was Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

AARD has 21.82 million shares outstanding. The number of shares has increased by 245.54% in one year.

Current Share Class	21.82M
Shares Outstanding	21.82M
Shares Change (YoY)	+245.54%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	16.33%
Owned by Institutions (%)	23.22%
Float	10.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.99
P/TBV Ratio	0.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.06, with a Debt / Equity ratio of 0.00.

Current Ratio	8.06
Quick Ratio	7.86
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -58.79% and return on invested capital (ROIC) is -39.12%.

Return on Equity (ROE)	-58.79%
Return on Assets (ROA)	-36.54%
Return on Invested Capital (ROIC)	-39.12%
Return on Capital Employed (ROCE)	-85.90%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.75M
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.21% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-66.21%
50-Day Moving Average	4.73
200-Day Moving Average	9.74
Relative Strength Index (RSI)	38.10
Average Volume (20 Days)	189,742

Short Selling Information

The latest short interest is 1.01 million, so 4.65% of the outstanding shares have been sold short.

Short Interest	1.01M
Short Previous Month	1.26M
Short % of Shares Out	4.65%
Short % of Float	9.29%
Short Ratio (days to cover)	5.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-74.72M
Pretax Income	-69.87M
Net Income	-69.87M
EBITDA	-74.68M
EBIT	-74.72M
Earnings Per Share (EPS)	-$3.21

Balance Sheet

The company has $91.20 million in cash and $336,000 in debt, with a net cash position of $90.86 million or $4.16 per share.

Cash & Cash Equivalents	91.20M
Total Debt	336,000
Net Cash	90.86M
Net Cash Per Share	$4.16
Equity (Book Value)	86.99M
Book Value Per Share	3.99
Working Capital	81.98M

Cash Flow

In the last 12 months, operating cash flow was -$61.65 million and capital expenditures -$95,000, giving a free cash flow of -$61.75 million.

Operating Cash Flow	-61.65M
Capital Expenditures	-95,000
Depreciation & Amortization	42,000
Net Borrowing	n/a
Free Cash Flow	-61.75M
FCF Per Share	-$2.83

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AARD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-245.54%
Shareholder Yield	-245.54%
Earnings Yield	-81.28%
FCF Yield	-71.84%

Analyst Forecast

The average price target for AARD is $15.44, which is 308.47% higher than the current price. The consensus rating is "Buy".

Price Target	$15.44
Price Target Difference	308.47%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1